Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $1.99
Tweet
Share
E-mailGet Alerts CLDI Hot Sheet
Join SI Premium – FREE
Calidi Biotherapeutics (NYSE: CLDI) reported Q2 EPS of ($1.99).
For earnings history and earnings-related data on Calidi Biotherapeutics (CLDI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q2 EPS by 6c, Offers Guidance
- NVIDIA reports 9.3% passive stake in Nebius
- Farmers & Merchants Bancorp (FMCB) Reports Q2 EPS of $36.39
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
